arrow
M

Marie-Louise Vachon

Université Laval
H指数:12
被引数:633

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18–49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years

AS01E佐剂呼吸道合胞病毒(RSV)前融合F蛋白疫苗在18~49岁高风险RSV疾病成人中的免疫原性和安全性,与≥60岁成人比较。

2026-02-270
OA
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning

使用监督机器学习预测加拿大hiv-hcv合并感染人群中抑郁症状的存在

2022-08-123
OAAI
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry

在DAA经验丰富的患者中使用Sofosbuvir/Velpatasvir/Voxilaprevir进行挽救治疗: 来自加拿大前瞻性注册表的结果

2021-03-0216
PRE
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

消除结构性障碍: 不受限制的访问对人类免疫缺陷病毒患者接受丙型肝炎治疗的影响

2019-08-2829
OAAI
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study
2017-05-2328
OAAI